Increased ICP

Increased intracranial pressure is an elevation of pressure within the cranial vault above 20 mmHg, caused by expanding mass lesions, cerebral edema, or impaired cerebrospinal fluid circulation, potentially leading to brain herniation and death.

Relevant Anatomy & Physiology

Etiology (with Focus on Hong Kong)

Organised by the Monro-Kellie components:

1. Increased Brain Volume

Pathophysiology: The Chain of Events

Let's put it all together from first principles:

Classification

Clinical Features

Clinical features depend on age, cause, chronicity, and brain compliance [1].

C. Herniation Syndromes

Herniation occurs when a pressure gradient drives brain tissue from one compartment to another across a rigid dural fold.

Herniation and ICP Monitoring Summary

Additional Key Concepts

Differential Diagnosis of Raised Intracranial Pressure

Systematic DDx Organised by Monro-Kellie Component

References

[1] Lecture slides: GC 111. Raised intracranial pressure and hydrocephalus.pdf (pp. 2, 8–9, 14–15) [2] Senior notes: Ryan Ho Neurology.pdf (pp. 155, 158) [3] Senior notes: maxim.md (Intracranial tumours, hydrocephalus, and ICH sections) [4] Senior notes: maxim.md (ICH and cerebral venous thrombosis sections) [5] Senior notes: felixlai.md (ICP causes and pathophysiology sections) [6] Senior notes: Ryan Ho Neurology.pdf (p. 205, Secondary brain injury) [7] Senior notes: Ryan Ho Fundamentals.pdf (p. 339) [8] Senior notes: Ryan Ho Opthalmology.pdf (pp. 85, 88, 90) [9] Senior notes: Ryan Ho Diagnostic Radiology.pdf (pp. 41–42) [10] Senior notes: Ryan Ho Respiratory.pdf (p. 79) [11] Senior notes: Ryan Ho Cardiology.pdf (p. 182) [12] Senior notes: Ryan Ho Endocrine.pdf (p. 107) [13] Senior notes: Ryan Ho Fundamentals.pdf (pp. 312–315)

Diagnostic Criteria for Raised ICP

Raised ICP is fundamentally a pathophysiological state, not a stand-alone diagnosis with a single set of diagnostic criteria the way, say, rheumatoid arthritis has ACR/EULAR criteria. Instead, the "diagnosis" involves two parallel tracks:

  1. Recognising that ICP is elevated (clinical features ± direct measurement)
  2. Identifying the underlying cause (neuroimaging ± LP ± targeted investigations)

There is, however, one condition — Idiopathic Intracranial Hypertension (IIH) — that does have formal diagnostic criteria because it is a diagnosis of exclusion where you need to prove the ICP is elevated AND that no structural cause exists.


Investigation Modalities: Key Findings & Interpretations

Management of Raised Intracranial Pressure

Detailed Treatment Modalities

Treatment by Any Doctor (Tier 0 — General Measures)

Treatment of Raised ICP — By any doctor: [1]

  • Head elevation
  • Optimise ventilation
  • Maintain MAP
  • Osmotherapy
  • Sedation
  • Optimise electrolyte/glucose level
  • Prevent/Control seizure
  • Prevent pyrexia

First-Tier Medical Therapy (Tier 1)

8. Osmotherapy

The two agents used are IV mannitol and hypertonic saline. Both work by creating an osmotic gradient across an intact BBB, drawing water from the brain's extracellular space into the intravascular compartment.

Second-Tier Medical Therapy (Tier 2 — Refractory ICP)

By neurosurgeon/ICU: [1]

  • ICP monitoring + CSF drainage
  • Controlled hyperventilation
  • Barbiturate coma
  • Surgical removal of SOL
  • Decompressive craniectomy

Neurosurgical Interventions (Tier 3)

References

[1] Lecture slides: GC 111. Raised intracranial pressure and hydrocephalus.pdf (pp. 9–10, 14) [2] Senior notes: Ryan Ho Neurology.pdf (pp. 156–157) [4] Senior notes: maxim.md (ICH management section) [5] Senior notes: felixlai.md (ICP management and treatment sections) [7] Senior notes: Ryan Ho Fundamentals.pdf (p. 339) [8] Senior notes: Ryan Ho Opthalmology.pdf (p. 90) [15] Senior notes: Ryan Ho Neurology.pdf (p. 163) [17] Senior notes: Ryan Ho Urogenital.pdf (p. 17) [18] Senior notes: maxim.md (Severe TBI management section) [19] Senior notes: Ryan Ho GI.pdf (p. 207) [20] Senior notes: Ryan Ho Neurology.pdf (p. 81) [21] Senior notes: Ryan Ho Urogenital.pdf (p. 98)

Complications of Raised Intracranial Pressure

Raised ICP generates complications through two fundamental mechanisms we established at the start of these notes:

  1. Global: ↓ CPP → ↓ CBF → cerebral ischaemia
  2. Focal: Pressure gradients across dural compartments → brain herniation → brainstem compression

Additionally, both the underlying cause of raised ICP and the treatments themselves carry their own complications. A comprehensive approach therefore considers complications in three domains: (A) Direct consequences of raised ICP itself, (B) Complications of the underlying disease, and (C) Complications of treatment (iatrogenic).


A. Direct Complications of Raised ICP

6. Endocrine and Electrolyte Complications

B. Complications of the Underlying Disease

C. Complications of Treatment (Iatrogenic)

References

[1] Lecture slides: GC 111. Raised intracranial pressure and hydrocephalus.pdf (pp. 9, 17) [2] Senior notes: Ryan Ho Neurology.pdf (pp. 153, 156–157, 160) [3] Senior notes: maxim.md (Complications of CSF shunt section) [5] Senior notes: felixlai.md (ICP treatment, decompressive craniectomy complications, hydrocephalus sections) [6] Senior notes: Ryan Ho Neurology.pdf (p. 205, Secondary brain injury) [7] Senior notes: Ryan Ho Fundamentals.pdf (p. 339) [8] Senior notes: Ryan Ho Opthalmology.pdf (p. 90) [15] Senior notes: Ryan Ho Neurology.pdf (pp. 145, 163) [17] Senior notes: Ryan Ho Urogenital.pdf (p. 17) [18] Senior notes: maxim.md (Severe TBI management section) [19] Senior notes: Ryan Ho GI.pdf (p. 207) [22] Senior notes: maxim.md (SAH complications section) [23] Senior notes: felixlai.md (Stroke complications and prognosis section)

High Yield Summary — Etiology & pathophysiology

Definition: Sustained intracranial pressure above physiological range; often treatment threshold ~20–22 mmHg in adults (context-dependent).

Normal: Adult ~10–15 mmHg; infant lower; CPP = MAP − ICP (or MAP − JVP when extracranial venous pressure is the effective downstream pressure).

Monro–Kellie–Burrows: Fixed skull volume → brain + blood + CSF; compensation via CSF displacement then venous egress; then steep ICP rise (compliance curve).

Drivers of ↑ICP: Mass (tumour, haematoma), cerebral oedema (vasogenic BBB leak vs cytotoxic cellular swelling vs interstitial transependymal CSF), impaired venous outflow, hydrocephalus, status epilepticus, hypercapnia, fever.

Cushing reflex (late): ↑BP, bradycardia, irregular respiration — brainstem compression; not reliable early warning.

IIH (pseudotumour cerebri): Obese young women; elevated ICP with normal imaging (except empty sella / slit ventricles); CN VI palsy common; visual field loss from papilloedema — preserve sight.

High Yield Summary — Differential diagnosis

Think by mechanism: Space-occupying lesion, diffuse oedema (TBI, stroke, metabolic), CSF pathway failure (hydrocephalus), venous obstruction (sinus thrombosis), malignant hypertension, hypercapnia, drugs/toxins, IIH.

Mimics of ↑ICP headache: Migraine, CSF hypotension, cervical pathology, medication overuse — but true localising neuro signs + papilloedema demand urgent imaging.

Herniation patterns: Uncal (unilateral pupil, contralateral hemiparesis may be "false localising"); central; tonsillar (respiratory arrest risk).

High Yield Summary — Diagnosis & monitoring

Clinical: GCS trend, pupil size/reactivity, posturing, CN VI, fundoscopy (papilloedema often late in acute trauma).

Imaging: Non-contrast CT emergency — mass, midline shift, basal cistern effacement, hydrocephalus, blood. MRI when stable for aetiology.

Invasive ICP monitoring: EVD therapeutic + monitoring; parenchymal bolt — indications per TBI protocol and neurosurgical context (often GCS ≤8 with abnormal CT in severe TBI cohorts — follow current guideline nuance).

Don't forget: ABCDE before chasing numbers; hypotension and hypoxia worsen outcome more than a single ICP reading.

High Yield Summary — Management

Tier 0 — General (any doctor): Airway (intubate if GCS ≤8 / failing protection), oxygen, normocapnia (avoid routine prolonged hyperventilation), maintain MAP for CPP ~60–70, head-up ~30°, midline neck, treat seizures, pyrexia, euvolaemia, analgesia/sedation.

Tier 1 — Osmotherapy: Mannitol 0.25–1 g/kg (avoid if hypovolaemic / shocked; foley — diuresis) or hypertonic saline (central line for high concentrations).

Tier 2 — Brief hyperventilation: PaCO₂ 30–35 mmHg only short bridge — vasoconstriction → ↓CBF → ischaemia risk if prolonged.

Tier 3 — Advanced ICU / neurosurgery: Barbiturate coma, decompressive craniectomy, therapeutic hypothermia (select adult contexts — know exam frame used locally).

Surgical cause control: Evacuate haematoma, resect tumour, EVD for hydrocephalus.

Avoid: Steroids not for TBI (harm — CRASH); jugular lines / tight collars impairing venous drainage.

High Yield Summary — Complications

Brain: Ischaemia from low CPP, herniation, stroke from herniation-related vessel compression, Duret haemorrhages.

Systemic: ARDS from aggressive fluids, renal injury from mannitol, hypernatraemia, rebound ICP if osmotherapy withdrawn abruptly.

IIH-specific: Permanent visual lossserial fields, fundoscopy, consider emergent optic nerve sheath fenestration if shunt/ medical Rx failing.

Monitoring risks: Haemorrhage at catheter site, infection.

On this page

No Headings